Revolutionizing cancer research, new drug screening approach with vascularized cancer organoid platform mimicking patient tumor microenvironment

被引：0
|
作者：
Lee, Mingyun
Yoon, Yeo-Joon
Lee, Yong-Soo
Rheey, Jinguen
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4243
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4243
引用
收藏
页数：2
相关论文
共 50 条
  • [31] DEVELOPMENT OF PATIENT-DERIVED KIDNEY CANCER ORGANOID; APPLICATION TO DRUG SCREENING MODELS AND ITS CHALLENGES
    Kazama, Akira
    Bilim, Vladimir
    Tomita, Yoshihiko
    JOURNAL OF UROLOGY, 2022, 207 (05): : E704 - E705
  • [32] Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer
    Zhao, Yi
    Li, Shangru
    Zhu, Lefan
    Huang, Mingle
    Xie, Yubin
    Song, Xinming
    Chen, Zhihui
    Lau, Harry Cheuk-Hay
    Sung, Joseph Jao-Yiu
    Xu, Lixia
    Yu, Jun
    Li, Xiaoxing
    CELL REPORTS MEDICINE, 2024, 5 (07)
  • [33] Patient-Derived Bladder Cancer Organoid Models in Tumor Biology and Drug Testing: A Systematic Review
    Medle, Benjamin
    Sjodahl, Gottfrid
    Eriksson, Pontus
    Liedberg, Fredrik
    Hoglund, Mattias
    Bernardo, Carina
    CANCERS, 2022, 14 (09)
  • [34] Patient-derived MTAP-deleted bladder cancer organoid model: A unique platform for drug development
    Schwermann, Maximilian
    Carneiro, Benedito
    Lu, Shaolei
    De Souza, Andre
    Hadfield, Matthew
    Mega, Anthony
    Lagos, Galina
    Khaleel, Sari
    Golijanin, Dragan
    Holder, Sheldon
    Srinivasan, Praveen
    MacDonald, William
    George, Andrew
    Zhou, Lanlan
    Zhang, Leiqing
    El-Deiry, Wafik
    CANCER RESEARCH, 2024, 84 (06)
  • [35] Miniaturization and characterization of patient derived hepatocellular carcinoma tumor organoid cultures for cancer drug discovery applications
    Close, David A.
    Johnston, Paul A.
    SLAS DISCOVERY, 2025, 30
  • [36] Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoid Technology: Progress and Challenges
    Li, Jingwei
    Liu, Jianhua
    Xia, Wuzheng
    Yang, Hongwei
    Sha, Weihong
    Chen, Hao
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
  • [37] A vascularized breast cancer spheroid platform for the ranked evaluation of tumor microenvironment-targeted drugs by light sheet fluorescence microscopy
    Ascheid, David
    Baumann, Magdalena
    Pinnecker, Jurgen
    Friedrich, Mike
    Szi-Marton, Daniel
    Medved, Cornelia
    Bundalo, Maja
    Ortmann, Vanessa
    Oztuerk, Asli
    Nandigama, Rajender
    Hemmen, Katherina
    Erguen, Sueleymann
    Zernecke, Alma
    Hirth, Matthias
    Heinze, Katrin G.
    Henke, Erik
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [38] CLINICAL TRIALS ACCRUAL HUDDLES: A NEW PATIENT SCREENING APPROACH FOR THE COMMUNITY CANCER RESEARCH PROGRAM
    Ward, Kim
    Arrowood, Christy
    Lowe, Catherine
    Owen, Lynda
    Sutton, Linda
    ONCOLOGY NURSING FORUM, 2014, 41 (02) : E92 - E93
  • [39] Application of triple negative breast cancer patient-derived organoid and xenograft model for drug screening.
    Ryu, Seungyeon
    Kim, Hoe Suk
    Kim, Jung Eun
    Yoon, So-Hyun
    Lee, Sangeun
    Baek, Moonjou
    Lee, Han-Byoel
    Lee, Dong Woo
    Ku, Bosung
    Han, Wonshik
    CANCER RESEARCH, 2022, 82 (12)
  • [40] Novel patient-derived tumor organoid models reveal growth-factor dependencies in neuroendocrine tumors and serve as a platform for neuroendocrine cancer research
    Dayton, T.
    Alcala, N.
    Moonen, L.
    van den Berg, J.
    Buikhuisen, W.
    Speel, E. J.
    Valk, G. D.
    Tesselaar, M. E. T.
    Vriens, M.
    Foll, M.
    Fernandez-Cuesta, L.
    Clevers, H.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 38 - 38
12345